Karthik Chetlapalli

Project Title: The Portrayal of Efficacy and Safety in FDA Press Releases for Novel Drug Approvals

Karthik Chetlapalli is a medical student at the Yale School of Medicine. His research interests include regulations around claims made in public and private media, clinical trial incentives and design within oncology accelerated approval, and equitable, competitive drug pricing. His CERSI Scholars project aims to study the nature of FDA press releases for drug approvals and assess quantitative versus qualitative language use when conveying drug risk and efficacy. This work has the potential to improve the quality of drug approval communications in a manner that is more accessible and readily understood by the public.